Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Soluble Uric Acid Activates the NLRP3 Inflammasome

Full text
Author(s):
Show less -
Braga, Tarcio Teodoro ; Forni, Maria Fernanda ; Correa-Costa, Matheus ; Ramos, Rodrigo Nalio ; Barbuto, Jose Alexandre ; Branco, Paola ; Castoldi, Angela ; Hiyane, Meire Ioshie ; Davanso, Mariana Rodrigues ; Latz, Eicke ; Franklin, Bernardo S. ; Kowaltowski, Alicia J. ; Saraiva Camara, Niels Olsen
Total Authors: 13
Document type: Journal article
Source: SCIENTIFIC REPORTS; v. 7, JAN 13 2017.
Web of Science Citations: 41
Abstract

Uric acid is a damage-associated molecular pattern (DAMP), released from ischemic tissues and dying cells which, when crystalized, is able to activate the NLRP3 inflammasome. Soluble uric acid (sUA) is found in high concentrations in the serum of great apes, and even higher in some diseases, before the appearance of crystals. In the present study, we sought to investigate whether uric acid, in the soluble form, could also activate the NLRP3 inflammasome and induce the production of IL-1 beta. We monitored ROS, mitochondrial area and respiratory parameters from macrophages following sUA stimulus. We observed that sUA is released in a hypoxic environment and is able to induce IL-1 beta release. This process is followed by production of mitochondrial ROS, ASC speck formation and caspase-1 activation. Nlrp3(-/-) macrophages presented a protected redox state, increased maximum and reserve oxygen consumption ratio (OCR) and higher VDAC protein levels when compared to WT and Myd88(-/-) cells. Using a disease model characterized by increased sUA levels, we observed a correlation between sUA, inflammasome activation and fibrosis. These findings suggest sUA activates the NLRP3 inflammasome. We propose that future therapeutic strategies for renal fibrosis should include strategies that block sUA or inhibit its recognition by phagocytes. (AU)

FAPESP's process: 13/07937-8 - Redoxome - Redox Processes in Biomedicine
Grantee:Ohara Augusto
Support type: Research Grants - Research, Innovation and Dissemination Centers - RIDC
FAPESP's process: 14/06992-8 - Cellular, molecular and immunological mechanisms generated through NLRP activation
Grantee:Tárcio Teodoro Braga
Support type: Scholarships in Brazil - Post-Doctorate
FAPESP's process: 12/02270-2 - New cellular, molecular and immunological mechanisms involved in acute and chronic renal injury: the search for new therapeutical approaches
Grantee:Niels Olsen Saraiva Câmara
Support type: Research Projects - Thematic Grants